Search

everythinglearnresearchcommunity

for

Search:↓

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Long-term use of a certain medication can worsen erectile function in aged rats by damaging penile muscle cells.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Finasteride helps regrow hair and shrink prostate by reducing DHT, with some sexual side effects.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

Finasteride increases hair growth, prolongs hair cycle, and lowers dihydrotestosterone levels.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

Finasteride doesn't affect oral testosterone undecanoate, and high DHT levels may cause acne, prostate issues, and hair loss.

The new oral testosterone pill normalized testosterone levels and lowered SHBG in men with low testosterone.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Testosterone's muscle-building effects do not require its conversion to DHT.

Finasteride reduces scalp DHT levels, potentially treating male pattern baldness.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

A mix of Panax ginseng and bee-pollen may help prevent prostate enlargement in rats.

Testosterone and dihydrotestosterone treatments can help with penile growth in males with 5α-reductase type 2 deficiency, with dihydrotestosterone being more effective in infancy.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Finasteride lowers DHT levels and raises testosterone in a dose-dependent way.

Testosterone is crucial for development, growth, and various body functions in mammals.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.